Contributions of selective knockout studies to understanding cholinesterase disposition and function
- PMID: 20153304
- PMCID: PMC2912976
- DOI: 10.1016/j.cbi.2010.02.008
Contributions of selective knockout studies to understanding cholinesterase disposition and function
Abstract
The complete knockout of the acetylcholinesterase gene (AChE) in the mouse yielded a surprising phenotype that could not have been predicted from deletion of the cholinesterase genes in Drosophila, that of a living, but functionally compromised animal. The phenotype of this animal showed a sufficient compromise in motor function that precluded precise characterization of central and peripheral nervous functional deficits. Since AChE in mammals is encoded by a single gene with alternative splicing, additional understanding of gene expression might be garnered from selected deletions of the alternatively spliced exons. To this end, transgenic strains were generated that deleted exon 5, exon 6, and the combination of exons 5 and 6. Deletion of exon 6 reduces brain AChE by 93% and muscle AChE by 72%. Deletion of exon 5 eliminates AChE from red cells and the platelet surface. These strains, as well as knockout strains that selectively eliminate the AChE anchoring protein subunits PRiMA or ColQ (which bind to sequences specified by exon 6) enabled us to examine the role of the alternatively spliced exons responsible for the tissue disposition and function of the enzyme. In addition, a knockout mouse was made with a deletion in an upstream intron that had been identified in differentiating cultures of muscle cells to control AChE expression. We found that deletion of the intronic regulatory region in the mouse essentially eliminated AChE in muscle and surprisingly from the surface of platelets. The studies generated by these knockout mouse strains have yielded valuable insights into the function and localization of AChE in mammalian systems that cannot be approached in cell culture or in vitro.
Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
Figures


Similar articles
-
Acetylcholinesterase (AChE) gene modification in transgenic animals: functional consequences of selected exon and regulatory region deletion.Chem Biol Interact. 2005 Dec 15;157-158:79-86. doi: 10.1016/j.cbi.2005.10.012. Epub 2005 Nov 9. Chem Biol Interact. 2005. PMID: 16289062
-
Near-complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase.J Neurochem. 2012 Sep;122(5):1065-80. doi: 10.1111/j.1471-4159.2012.07856.x. Epub 2012 Aug 3. J Neurochem. 2012. PMID: 22747514
-
Remodeling of the neuromuscular junction in mice with deleted exons 5 and 6 of acetylcholinesterase.J Mol Neurosci. 2006;30(1-2):99-100. doi: 10.1385/JMN:30:1:99. J Mol Neurosci. 2006. PMID: 17192646
-
The origin of the molecular diversity and functional anchoring of cholinesterases.Neurosignals. 2002 May-Jun;11(3):130-43. doi: 10.1159/000065054. Neurosignals. 2002. PMID: 12138250 Review.
-
Congenital myasthenic syndromes with acetylcholinesterase deficiency, the pathophysiological mechanisms.Ann N Y Acad Sci. 2018 Feb;1413(1):104-110. doi: 10.1111/nyas.13595. Ann N Y Acad Sci. 2018. PMID: 29405353 Review.
Cited by
-
Dysregulated Homeostasis of Acetylcholine Levels in Immune Cells of RR-Multiple Sclerosis Patients.Int J Mol Sci. 2016 Nov 30;17(12):2009. doi: 10.3390/ijms17122009. Int J Mol Sci. 2016. PMID: 27916909 Free PMC article.
-
Planarian cholinesterase: molecular and functional characterization of an evolutionarily ancient enzyme to study organophosphorus pesticide toxicity.Arch Toxicol. 2018 Mar;92(3):1161-1176. doi: 10.1007/s00204-017-2130-7. Epub 2017 Nov 22. Arch Toxicol. 2018. PMID: 29167930 Free PMC article.
-
Trans-acting factors governing acetylcholinesterase mRNA metabolism in neurons.Front Mol Neurosci. 2012 Mar 22;5:36. doi: 10.3389/fnmol.2012.00036. eCollection 2012. Front Mol Neurosci. 2012. PMID: 22461767 Free PMC article.
-
Naturally occurring variations in the human cholinesterase genes: heritability and association with cardiovascular and metabolic traits.J Pharmacol Exp Ther. 2011 Jul;338(1):125-33. doi: 10.1124/jpet.111.180091. Epub 2011 Apr 14. J Pharmacol Exp Ther. 2011. PMID: 21493754 Free PMC article.
-
Construction and characterization of tetH overexpression and knockout strains of Acidithiobacillus ferrooxidans.J Bacteriol. 2014 Jun;196(12):2255-64. doi: 10.1128/JB.01472-13. Epub 2014 Apr 11. J Bacteriol. 2014. PMID: 24727223 Free PMC article.
References
-
- Li Y, Camp S, Rachinsky TL, Getman D, Taylor P. Gene structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression. J Biol Chem. 1991;266(34):23083–23090. - PubMed
-
- Taylor P, Radic Z. The cholinesterases: from genes to proteins. Annu Rev Pharmacol Toxicol. 1994;34:281–320. - PubMed
-
- Dobbertin A, Hrabovska A, Dembele K, Camp S, Taylor P, Krejci E, Bernard V. Targeting of acetylcholinesterase in neurons in vivo: a dual processing function for the proline-rich membrane anchor subunit and the attachment domain on the catalytic subunit. J Neurosci. 2009;29(14):4519–4530. - PMC - PubMed
-
- Chuang HY, Mahammad SF, Mason RG. Acetylcholinesterase, choline acetyltransferase, and the postulated acetylcholine receptor of canine platelets. Biochem Pharmacol. 1976;25(17):1971–1977. - PubMed
-
- Deutsch VR, Pick M, Perry C, Grisaru D, Hemo Y, Golan-Hadari D, Grant A, Eldor A, Soreq H. The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34(+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation. Exp Hematol. 2002;30(10):1153–1161. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources